Characterization of Neisseria meningitidis Carriage in Military at Joint Base San Antonio, Texas, June-August 2024
Military Medicine · 28.04.2026
DOI: 10.1093/milmed/usag207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Military Medicine, online erschienen am 28.04.2026. Verfasst von Kevin Kashuba-Shanahan und 10 weiteren Autor:innen. Beteiligte Einrichtung: San Antonio Uniformed Services Health Educational Consortium Internal Medicine Residency, Joint Base San Antonio, TX 78234, United States. Die Arbeit nennt 18 Literaturangaben. Gefördert von: 59th Medical Wing Clinical Investigations Program.
Abstract (Originalsprache)
Introduction
The bacteria, Neisseria meningitidis, is a frequent colonizer of the oropharynx, but can also lead to invasive disease with encapsulated strains. All military services currently use a quadrivalent polysaccharide vaccine against serogroups A, C, W, and Y to prevent outbreaks among trainees. With the introduction of novel vaccines against serogroup B, this study evaluated the current carriage of N. meningitidis among military trainees. Materials and Methods Between June and August 2024, a sample of 909 military trainees received oropharyngeal sampling at the time of beginning basic military training before universal vaccination and penicillin administration. All isolates were serogrouped by polymerase chain reaction (PCR) and whole genome sequencing. This study was reviewed by the Lackland Institutional Review Board and determined to be occupational surveillance and not human research.
Results
Thirty-five (3.9%) trainees had carriage of N. meningitidis. While the PCR suggested, 11 (31%) isolates were encapsulated with Serogroup B, to be the most common colonizing isolate (n = 8, 22%). However, when characterized by whole genome sequencing, only one isolate, expressing serogroup C, was predicted to have a functional capsule.
Conclusions
These data demonstrate the continued threat of N. meningitidis in military training populations and the need for whole genome sequencing in characterizing colonizing isolates and the determination of vaccination policies. Furthermore, these data support the current policy of quadrivalent vaccination in the military training population.
Autor:innen und Institutionen
- San Antonio Uniformed Services Health Educational Consortium Internal Medicine Residency, Joint Base San Antonio, TX 78234, United States.
- Clinical Investigations and Research Support Lab, JBSA Lackland, Joint Base San Antonio, TX 78236, United States.
- Trainee Health Surveillance, JBSA Lackland, Joint Base San Antonio, TX 78236, United States.
- Infectious Disease Service, Brooke Army Medical Center, JBSA Fort Sam Houston, Joint Base San Antonio, TX 78234, United States.
- Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, United States.
ORCID-Profile: Kevin Kashuba-Shanahan, Ga On Jung, Brian G Casleton, John L Kiley, Joseph E Marcus
Förderung
- 59th Medical Wing Clinical Investigations Program
Zitieren
APA
Kashuba-Shanahan, K., Xia, H., Winkler, E. L., Casey, T. M., Jung, G. O., Osuna, A., Henrichs, L. E., Casleton, B. G., Kiley, J. L., Gibbons, T., & Marcus, J. E. (2026). Characterization of Neisseria meningitidis Carriage in Military at Joint Base San Antonio, Texas, June-August 2024. Military Medicine. https://doi.org/10.1093/milmed/usag207
Vancouver
Kashuba-Shanahan K, Xia H, Winkler EL, Casey TM, Jung GO, Osuna A, et al. Characterization of Neisseria meningitidis Carriage in Military at Joint Base San Antonio, Texas, June-August 2024. Military Medicine. 2026. doi:10.1093/milmed/usag207
BibTeX
@article{KashubaShanahan2026,
author = {Kashuba-Shanahan, Kevin and Xia, Hui and Winkler, Erin L and Casey, Theresa M and Jung, Ga On and Osuna, Angela and Henrichs, Lori E and Casleton, Brian G and Kiley, John L and Gibbons, Thomas and Marcus, Joseph E},
title = {Characterization of Neisseria meningitidis Carriage in Military at Joint Base San Antonio, Texas, June-August 2024},
journal = {Military Medicine},
year = {2026},
doi = {10.1093/milmed/usag207}
}
EUVIMED